HLSENROLLED 26RS-987 REENGROSSED Regular Session HOUSE BILL NO.

761 BY REPRESENTATIVES HILFERTY, ADAMS, BAYHAM, BILLINGS, WILFORD CARTER, CHASSION, FISHER, GREEN, LACOMBE, LAFLEUR, TERRY LANDRY, LARVADAIN, MARCELLE, MARTINEZ, PHELPS, SPELL, TAYLOR, WALTERS, AND ZERINGUE HEALTH/CANCER:AN ACT To amend and reenact R.S.

Provides with respect to the advisory board created to recommend new treatments for rare cancers AN ACT To amend and reenact R.S.

rulemaking A.Thereisherebycreatedwithinthedepartmentanadvisoryboardthatshall review and provide medical recommendations to approve new treatments for rare cancers.cancers.The advisory board shall be composed of the following seventeen members:

The advisory board shall be composed of the following seventeen members:

Page(5) 1TheexecutivedirectorordesigneeofTakingAimatCancerinLouisiana ofthe 3Cancer CODING:Association of Louisiana.

Wordsinstruckthroughtypearedeletionsfromexistinglaw;wordsunderscored are additions.

HLS 26RS-987 REENGROSSED HB NO.

761 (5) TheexecutivedirectorordesigneeofTakingAimatCancerinLouisiana The Cancer Association of Louisiana.

(11)Page A1 designee of the2 LSUCODING: Health Sciences Center at New Orleans, specializing in oncology.

Wordsinstruckthroughtypearedeletionsfromexistinglaw;wordsunderscored are additions.

HB NO.

761 ENROLLED (11) A designee of the LSU Health Sciences Center at New Orleans, specializing in oncology.

B.(1) The chairperson of the advisoryadvisoryboard board shall be the executive director or designee of the Louisiana Cancer Research Center.

Within thirty No later than forty-five days of eachafter meeting,eachmeeting, the advisoryadvisoryboard board shall compile a report of its findings and submit a formal written report to the legislature House Committee on Insurance and the Senate Committee on Insurance.

The commissioner may promulgate and adopt administrative rules and regulationsinaccordancewithregulations in accordancewith theAdministrative ProcedureActasarenecessaryto implement the provisions of this Section.

PageSPEAKER 2OF ofTHE 3HOUSE CODING:OF REPRESENTATIVES PRESIDENT OF THE SENATE GOVERNOR OF THE STATE OF LOUISIANA APPROVED:

Wordsinstruckthroughtypearedeletionsfromexistinglaw;wordsunderscoredPage are2 additions.of 2 CODING:

HLS 26RS-987 REENGROSSED HB NO.

761 DIGEST ThedigestprintedbelowwaspreparedbyHouseLegislative Services.

It constitutes nopart of the legislative instrument.

The keyword, one-liner, abstract, and digest do not constitute part of the law or proof or indicia of legislative intent.

[R.S.

1:13(B) and 24:177(E)] HB 761 Reengrossed 2026 Regular Session Hilferty Abstract:

Revises the composition of the advisory board for rare cancer treatments and provides for meetings and reporting requirements.

Present law provides that the chairperson of the advisory board is the executive director or designee of the La.

Cancer Research Center.

Proposed law changes the executive director or a designee of Taking Aim at Cancer in La.

to the executive director of the Cancer Association of Louisiana to serve on the board.

Proposed law revises theboard’scomposition byincreasingthe number of oncologists who sit on the board.

Present law creates an advisory board within the Dept.

of Insurance to review and provide medical recommendations for new treatments for rare cancers.

Present law requires the advisory board to hold quarterly public meetings unless otherwise provided.

Proposed law changes the deadline for submitting written reports to the legislature from 30 to 45 days after each meeting and also requires that the reports be submitted to the House and Senate committees on insurance, instead of the legislature.

Present law authorizes the commissioner to promulgate rules necessary to implement the provisions of present law.

Proposed law retains present law.

Effective upon signature of governor or lapse of time for gubernatorial action.

(Amends R.S.

22:1076.1) Summary of Amendments Adopted by House The House Floor Amendments to the engrossed bill:

1.